ArticleJournal of assisted reproduction and genetics2025
Ovarian stimulation and retrieval outcomes in transgender males maintained on testosterone: a case series.
Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to report on three cases of transgender men who continued testosterone therapy throughout controlled ovarian hyperstimulation for fertility preservation.
methodsThis was a retrospective case series of three transgender men who presented for oocyte cryopreservation at a university-affiliated fertility clinic and continued gender-affirming testosterone therapy up until or during the controlled ovarian hyperstimulation protocol. The primary outcomes were the number of oocytes retrieved, the number of mature oocytes retrieved, and the total gonadotrophin dose required during stimulation.
resultsThe average age of patients in this series was 29.5 years, with an average BMI of 31 kg/m
conclusionsThis is the largest case series of patients who continued testosterone during ovarian stimulation, with the widest range of testosterone dosing reported, and the first report of a self-carried pregnancy after COS on testosterone. While there is no long-term data as yet, these early findings are reassuring for patients and indicate that proceeding with a stimulation cycle without a testosterone washout period, or continuing testosterone during the cycle, may be a reasonable option, thereby increasing the accessibility of fertility preservation for gender-diverse and transgender individuals who wish to continue testosterone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.